(a) Commercial feed, other than customer-formula feed, shall be labeled with the information prescribed in this rule on the principal display panel of the product and in the following format:

1. (1) Product name and brand name, if any, as stipulated in 2 CAR § 25-103(b);
2. (2) If a drug is used, label as stipulated in 2 CAR § 25-103(c);
3. (3) Purpose statement as stipulated in 2 CAR § 25-103(d);
4. (4) Guaranteed analysis as stipulated in 2 CAR § 25-103(e);
5. (5) Feed ingredients as stipulated in 2 CAR § 25-103(f);
6. (6) Directions for use and precautionary statements as stipulated in 2 CAR § 25-103(g);
7. (7) Name and principal mailing address of the manufacturer or person responsible for distributing the feed as stipulated in 2 CAR § 25-103(h); and
8. (8) Quantity statement.

(b)

1. (1) The information required in subdivisions (a)(1)–(5) and (7)–(8) of this section must appear in its entirety on one (1) side of the label or on one (1) side of the container.

2. (2)

   1. (A) The information required by subdivision (a)(6) of this section shall be displayed in a prominent place on the label or container but not necessarily on the same side as the above information.
   2. (B) When the information required by subdivision (a)(6) of this section is placed on a different side of the label or container, it must be referenced on the front side with a statement such as "See back of label for directions for use".
3. (3) None of the information required by this section shall be subordinated or obscured by other statements or designs.

(c) Customer-formula feed shall be accompanied with the information prescribed in this section using labels, invoice, delivery ticket, or other shipping document bearing the following information:

1. (1) The name and address of the manufacturer;
2. (2) The name and address of the purchaser;
3. (3) The date of sale or delivery;
4. (4) The customer-formula feed name and brand name, if any;
5. (5) The product name and net quantity of each registered commercial feed and each other ingredient used in the mixture;
6. (6) The direction for use and precautionary statements as required by 2 CAR §§ 25-107 and 25-108; and

7. (7) If a drug containing product is used:

   1. (A) The purpose of the medication (claim statement); and
   2. (B) The established name of each active drug ingredient and the level of each drug used in the final mixture expressed in accordance with 2 CAR § 25-104(d).